The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Cirrhosis, Liver Clinical Trial

— ELSL  

Official title:

The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05325424
• Other study ID #: YZUC-006
• Status: Recruiting
• Phase: N/A
• Start date: March 1, 2022
• Est. completion date: October 1, 2024

Study information

• Verified date: December 2023
• Source: Northern Jiangsu People's Hospital
• Contact: Guo-Qing Jiang, MD
• Phone: +8651487373272
• Email: jgqing2003[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, the investigators compared the improvement of liver reserve function related indicators in patients with liver cirrhosis after laparoscopic splenectomy. To determine whether surgical treatment can help enhance postoperative liver reserve function and improve patient prognosis.

Description:

The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team performed laparoscopic splenectomy, and the same nursing team performed the nursing after the operation. Then, patients received a unified treatment plan after surgery, including medication, other treatments and follow-up. During the treatment, the liver reserve function related indicators of the patients were monitored before surgery, 3, 6, 12 and 24 months after surgery, including TBIL, DBIL, ALB, ALT, INR, PT, Child-Pugh, ascites, prealbumin, ICG-K, ICG-R 15 and ICG-T/2.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: October 1, 2024
• Est. primary completion date: October 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
• Splenomegaly with secondary hypersplenism, Platelet count < 50*10^9/L
• Informed consent to participate in the study

Exclusion Criteria:

• Hepatocellular carcinoma or any other malignancy,
• Child-Pugh grade C
• Recent peptic ulcer disease
• History of Hemorrhagic stroke
• Pregnancy.
• Uncontrolled Hypertension
• Bleeding portal hypertension
• Human immunodeficiency virus (HIV) infection

Related Conditions & MeSH terms

• Cirrhosis, Liver
• Fibrosis
• Liver Cirrhosis
• Splenectomy; Status

Intervention

Procedure:
• Laparoscopic splenectomy
The laparoscopic splenectomy was performed by the same surgical team.

Locations

Country	Name	City	State
China	Clinical Medical College of Yangzhou University	Yangzhou	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
Northern Jiangsu People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Liver reserve function ICG-K level at 3 months after surgery	The level of liver reserve function ICG-K level at 3 months after surgery.	3 months
Primary	Liver reserve function ICG-K level at 6 months after surgery.	The level of liver reserve function ICG-K level at 6 months after surgery.	6 months
Primary	Liver reserve function ICG-K level at 12 months after surgery	The level of liver reserve function ICG-K level at 12 months after surgery.	12 months
Primary	Liver reserve function ICG-K level at 24 months after surgery.	The level of liver reserve function ICG-K level at 24 months after surgery.	24 months
Primary	Liver reserve function ICG-R15 level at 3 months after surgery.	The level of liver reserve function ICG-R15 level at 3 months after surgery.	3 months
Primary	Liver reserve function ICG-R15 level at 6 months after surgery.	The level of liver reserve function ICG-R15 level at 6 months after surgery.	6 months
Primary	Liver reserve function ICG-R15 level at 12 months after surgery.	The level of liver reserve function ICG-R15 level at 12 months after surgery.	12 months
Primary	Liver reserve function ICG-R15 level at 24 months after surgery.	The level of liver reserve function ICG-R15 level at 24 months after surgery.	24 months
Primary	Liver reserve function ICG-T/2 level at 3 months after surgery.	The level of liver reserve function ICG-T/2 level at 3 months after surgery.	3 months
Primary	Liver reserve function ICG-T/2 level at 6 months after surgery.	The level of liver reserve function ICG-T/2 level at 6 months after surgery.	6 months
Primary	Liver reserve function ICG-T/2 level at 12 months after surgery.	The level of liver reserve function ICG-T/2 level at 12 months after surgery.	12 months
Primary	Liver reserve function ICG-T/2 level at 24 months after surgery.	The level of liver reserve function ICG-T/2 level at 24 months after surgery.	24 months